Tens of thousands of people suffer needless heart attacks and strokes every year because they aren't taking ...

Merck's Winrevair gains FDA priority review for PAH label update after ZENITH trial shows major reduction in serious events and strong clinical impact.

More than 39,000 deaths, nearly 100,000 non-fatal heart attacks and up to 65,000 strokes in the U.S. could be prevented if ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

Tens of thousands of people suffer needless heart attacks and strokes every year because they aren't taking cholesterol-lowering drugs, a new study says.

In its order, CJ Upadhyaya-led bench directed PIL litigant to submit to CDSCO the scientific studies and data relied upon in ...

The analysis reveals a strong dominance of AI applications in oncology, comprising 72.8% of all included studies. This skew ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET ...

DelveInsight’s Metastatic Prostate Cancer Pipeline report depicts a robust space with 80+ active players working to develop ...

When it comes to cutting-edge health technology, Jecizer Biosciences is quickly becoming the name you’ve probably haven’t ...

The World Health Organization has added the variant, known formally as XFG, to its monitoring list. A dry, irritated throat ...